Expression of FGL2 was associated with susceptibility to murine hepatitis virus strain 3 (MHV-3) infection in vivo [11], and the FGL2 gene has been suggested as a potential target for treatment of fulminant viral hepatitis [11, 17, 18]. Here, FGL2 is linked to fulminant viral hepatitis.